Proton therapy developer Ion Beam Applications (IBA) has signed a contract for its proton therapy system with a Chinese company.
Guangdong Hengju Medical Technologies of Guangzhou will install the unit, the first proton therapy system in southern China, the company said. The agreement is worth 30 million euros ($37.3 million U.S.).
IBA will provide the new center with equipment from its ProteusPlus system, which will also include IBA's pencil-beam scanning capability. The facility will open in the summer of 2017, according to the company.